Delivery Order SPE2DB22D9239-SPE2DB26FDD89
- Not listed
- The U.S. government agency Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,840.66 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product JAKAFI 10 MG TABLET 60S. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program. The...
- The Defense Logistics Agency awarded a delivery order valued at $12,338.41 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of JAKAFI 20 mg tablets (60-count units). This firm fixed-price delivery order was issued on October 29, 2025, with an ultimate completion date of October 30, 2025, and does not utilize a set-aside designation. The award reflects DMS Pharmaceutical Group's competitive capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc. on July 14, 2025, for the supply of JAKAFI 10 mg tablets (60-count units). This firm fixed-price delivery order, which has an ultimate completion date of July 15, 2025, was issued without set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery from its Illinois location....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency valued at $41,245.02 for JAKAFI 15 MG tablets (60-count supply). The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's significant single-award Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $12,060.59 contract covers the delivery of JAKAFI 10 MG TABLET 60S, with a completion date of February 22, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract, SPE2DB, with the Defense Logistics Agency, valued at up to $4,999,999 through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $23,614.86 contract is for the supply of JAKAFI 25 MG TABLET 60S, a pharmaceutical product. This delivery order was issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB24FPQE6 with DLA, which has a ceiling value of up to $4,999,999 and provides for a broad range of...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count packaging). The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a $48.2 million delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count). This firm fixed-price delivery order, issued on September 22, 2025, with a completion date of September 23, 2025, was awarded without set-aside designation. The award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $24,231.30 to DMS Pharmaceutical Group Inc. for JAKAFI 10 mg tablets (60-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This delivery order was issued without a set-aside designation and represents a direct purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA, valued at $499.9 million through November 2026. DMS Pharmaceutical Group Inc., a...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,115.65, was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The award carries no set-aside designation and represents a single delivery order issued under DMS Pharmaceutical Group's larger...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB26FDD89Delivery Order
The Defense Logistics Agency awarded a $48,462.60 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of JAKAFI 10 mg tablets (60-count packages). The contract, executed on October 31, 2025, with an ultimate completion date of November 3, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The parent IDC, valued at $499.999 billion through December 31, 2036, positions DMS Pharmaceutical Group as a critical regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy designed to support recurring pharmaceutical supply needs of Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group has demonstrated substantial contracting performance as a federal pharmaceutical supplier, with extensive experience distributing a comprehensive portfolio including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to Department of Defense facilities. As a small business continuously registered in the System for Award Management since July 2001, the company competes effectively in unrestricted federal procurement and has received numerous delivery orders from the Defense Logistics Agency's Medical Supply Chain division. The current delivery order for JAKAFI, a specialty pharmaceutical used in the treatment of myelofibrosis, reflects the company's established capability to fulfill the diverse and specialized pharmaceutical requirements essential to military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.5k | 10/31/25 |